[Reduction of the Nordin index after therapy with oral alendronate in patients with postmenopausal osteoporosis].
The authors observe a significant reduction in value of the Nordin's Index (a sensible test for the screening of the "fast-losers" patients) in 10 women with post-menopausal osteoporosis after therapy with alendronate 5 mg daily per os for six months. The authors propound the measurement of the Nordin's Index in order to assess the alendronate's therapy per os in the post-menopausal osteoporosis.
Busi
S
S
Centro per l'Osteoporosi, Azienda U.S.L., Roma.
Catalano
A
A
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D019386:Alendronate; D015519:Bone Density / Q000187:drug effects; D001862:Bone Resorption / Q000188:drug therapy*; D004164:Diphosphonates / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008875:Middle Aged; D015663:Osteoporosis, Postmenopausal / Q000188:drug therapy*
D004164:Diphosphonates; D019386:Alendronate
Riduzione dell'indice di Nordin dopo trattamento con alendronato per os in pazienti con osteoporosi post-menopausale.